Open AccessPractical guidelines for the diagnosis and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM or transthyretin cardiac amyloidosis)
Author(s) -
S. N. Tereshchenko,
И. В. Жиров,
O. M. Moiseeva,
Т. В. Адашева,
А. А. Аншелес,
O. L. Barbarash,
A. S. Galyavich,
Alexandra Ya. Gudkova,
Dmitry A. Zateyshchikov,
Anna Kostareva,
Svetla. Nasonova,
S. V. Nedogoda,
Tamara Pecherina,
Д. В. Рыжкова,
В. Б. Сергиенко
Publication year - 2022
Publication title -
terapevtičeskij arhiv
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.181
H-Index - 14
eISSN - 2309-5342
pISSN - 0040-3660
DOI - 10.26442/00403660.2022.04.201465
Subject(s) - transthyretin , medicine , amyloidosis , differential diagnosis , intensive care medicine , cardiac amyloidosis , cardiomyopathy , amyloid (mycology) , disease , heart failure , pathology
This paper summarizes the data from updated international protocols and guidelines for diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM). The invasive and non-invasive diagnosis techniques and their combinations are briefly reviewed; the evidentiary foundations for each diagnostic option and tool are analyzed. The paper describes a customized algorithm for sequential diagnosis and differential diagnosis of patients with suspected ATTR-CM with allowance for the combination of clinical signs and diagnostic findings. Along with the awareness of primary care providers about the red flags of the disease and visualization criteria, as well as providing information to the patients about the possibility of performing therapy of ATTR amyloidosis and the risks of delayed diagnosis, the proposed algorithm enables timely patient routing and prescribing specific treatment.